Rebound Therapeutics
Date | Investors | Amount | Round |
---|---|---|---|
$16.5m | Series B | ||
N/A | Acquisition | ||
Total Funding | €15.0m |
Related Content
Recent News about Rebound Therapeutics
EditRebound Therapeutics is a privately held medical device company specializing in the development of innovative single-use, disposable devices designed to improve the procedural and clinical outcomes of minimally invasive surgical procedures. The company's flagship products, the Surgiscope System and Evacuator, are tailored for a variety of minimally invasive neurosurgical applications. Rebound Therapeutics serves healthcare providers and surgical centers, primarily operating within the medical technology and neurosurgery markets. The business model focuses on the development and commercialization of advanced surgical tools that enhance precision, safety, and efficiency during operations. Revenue is generated through the sale of these specialized devices to medical institutions and practitioners. The company is continually exploring additional clinical applications for its technology to expand its market reach and impact.
Keywords: medical device, minimally invasive, neurosurgery, single-use, disposable, access, imaging, illumination, Surgiscope, Evacuator.